These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36708557)

  • 1. Genetic Polymorphisms in ERCC1 Gene and Their Association with Response to Radiotherapy in Moroccan Patients with Nasopharyngeal Carcinoma.
    Benzeid R; Gihbid A; Tawfiq N; Benchakroun N; Bendahhou K; Benider A; Guensi A; El Benna N; Filali Maltouf A; Attaleb M; Chaoui I; Khyatti M; El Mzibri M
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):93-99. PubMed ID: 36708557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.
    Hui EP; Ma BB; Chan KC; Chan CM; Wong CS; To KF; Chan AW; Tung SY; Ng WT; Cheng AC; Lee VH; Chan SL; Loong HH; Kam MK; Leung SF; Ho R; Mo F; Ngan RK; Chan AT
    Cancer; 2015 Aug; 121(16):2720-9. PubMed ID: 25946469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
    Xu TP; Shen H; Liu LX; Shu YQ
    Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of ERCC1 gene polymorphisms on response to cisplatin based therapy in oral squamous cell carcinoma (OSCC) patients.
    Avinash Tejasvi ML; Maragathavalli G; Putcha UK; Ramakrishna M; Vijayaraghavan R; Anulekha Avinash CK
    Indian J Pathol Microbiol; 2020; 63(4):538-543. PubMed ID: 33154302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma.
    Jin H; Xie X; Wang H; Hu J; Liu F; Liu Z; Zhou J; Zhang Y; Xi X; Hu B; Liao Y; Tang J
    PLoS One; 2014; 9(7):e101256. PubMed ID: 25025378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERCC1 single nucleotide polymorphism C8092A, but not its expression is associated with survival of esophageal squamous cell carcinoma patients from Fujian province, China.
    Chen WH; Xin PL; Pan QX; Chen YY; Wang CR; Zhang ZS; Chen YF; Zhang CY; Cai WJ
    PLoS One; 2014; 9(9):e106600. PubMed ID: 25191856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy.
    Chen C; Wang F; Wang Z; Li C; Luo H; Liang Y; An X; Shao J; Li Y
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):315-22. PubMed ID: 23712330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The determination of relationship between "excision repair cross-complementing group 1" (ERCC1) gene T19007C and C8092A single nucleotide polymorphisms and clinicopathological parameters in non-small cell lung cancer.
    Koç E; Caner V; Büyükpınarbaşılı N; Tepeli E; Türk NS; Ozan Çetin G; Bağcı G
    Mol Biol Rep; 2012 Jan; 39(1):375-80. PubMed ID: 21553053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ERCC1 polymorphisms and susceptibility to nasopharyngeal carcinoma.
    Yang ZH; Dai Q; Kong XL; Yang WL; Zhang L
    Mol Carcinog; 2009 Mar; 48(3):196-201. PubMed ID: 18615480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis.
    Wei HB; Lu XS; Shang LH; Xu G; Hu J; Che DH; Liu F; Wu Y; Zhang GM; Yu Y
    Arch Med Res; 2011 Jul; 42(5):412-20. PubMed ID: 21827803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients.
    Takenaka T; Yano T; Kiyohara C; Miura N; Kouso H; Ohba T; Kometani T; Shoji F; Yoshino I; Maehara Y
    Lung Cancer; 2010 Jan; 67(1):101-7. PubMed ID: 19361884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between polymorphisms of ERCC1 and response in patients with advanced non-small cell lung cancer receiving cisplatin-based chemotherapy].
    Wang J; Zhang Q; Zhang H; Wang Q; Yang X; Gu Y; Zhang S
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):337-41. PubMed ID: 20677561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer.
    Moxley KM; Benbrook DM; Queimado L; Zuna RE; Thompson D; McCumber M; Premkumar P; Thavathiru E; Hines L; Moore KN
    Gynecol Oncol; 2013 Aug; 130(2):377-82. PubMed ID: 23632208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
    Obiedat H; Alrabadi N; Sultan E; Al Shatti M; Zihlif M
    BMC Med Genet; 2018 Jul; 19(1):112. PubMed ID: 29980176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between single nucleotide polymorphisms in DNA repair genes and the efficacy of radiotherapy in nasopharyngeal carcinoma patients.
    Benzeid R; Gihbid A; Tawfik N; Benchakroun N; Bendahhou K; Benider A; Guensi A; Benna NE; Maltouf AF; Mzibri ME; Attaleb M; Khyatti M; Chaoui I
    Contemp Oncol (Pozn); 2023; 27(1):28-34. PubMed ID: 37266339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; a Gynecologic Oncology Group study.
    Krivak TC; Darcy KM; Tian C; Bookman M; Gallion H; Ambrosone CB; Deloia JA
    Gynecol Oncol; 2011 Jul; 122(1):121-6. PubMed ID: 21496891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional single-nucleotide polymorphism in the ERCC1 gene alters the efficacy of narrowband ultraviolet B therapy in patients with active vitiligo in a Chinese population.
    Dai W; Zhou FB; Wei C; Wang XW; Guo S; Yi XL; Li K; Gao TW; Liu L; Li CY
    Br J Dermatol; 2015 Aug; 173(2):457-63. PubMed ID: 25965418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERCC1 C8092A polymorphism predicts fair survival outcome in Japanese patients with pharyngo-laryngeal squamous cell carcinoma.
    Hirakawa H; Ikegami T; Azechi S; Agena S; Uezato J; Kinjyo H; Yamashita Y; Tanaka K; Kondo S; Maeda H; Suzuki M; Gahana A
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):601-610. PubMed ID: 31749055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population.
    Ni M; Zhang WZ; Qiu JR; Liu F; Li M; Zhang YJ; Liu Q; Bai J
    Sci Rep; 2014 Feb; 4():4112. PubMed ID: 24531312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of ERCC1 mRNA Level from Receiver-Operator Characteristic and Pretreatment EBV-DNA Virus Load in Stage II Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy with Concurrent Cisplatin.
    Hua L; Chen S; Wei M; Shen Y; Long J; Lin Z; Meng Y; Guo C; Huang H; Tu X; Yao M
    Cancer Biother Radiopharm; 2022 Feb; 37(1):2-10. PubMed ID: 33764811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.